Cara Resuming Phase III Trial In Post-Op Pain After Clinical Hold Lifts
This article was originally published in The Pink Sheet Daily
Executive Summary
Novel analgesic can resume a Phase III study in post-surgical pain after findings of hypernatremia in a now-ended, high-dose cohort of the selective kappa opioid receptor agonist.